Income Statement (IMMUNOVANT)

BNP Paribas Financial Markets purchased a new stake in Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 85,201 sha… [+5024 chars]...

D. E. Shaw & Co. Inc. increased its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 8.4% in the fourth quarter, Holdings Channel reports. The firm owned 67,669 shares of the… [+4729 chars]...

The Manufacturers Life Insurance Company lowered its stake in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 2.1% during the fourth quarter, HoldingsChannel reports. The firm owned 35,908 … [+5441 chars]...

Dimensional Fund Advisors LP lessened its holdings in Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 12.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 403,747 shares of the co… [+5322 chars]...

ProShare Advisors LLC boosted its position in Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 18.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 23,300 shares of the company’s… [+5266 chars]...

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten brokerages that are presently covering the firm, MarketBeat.com reports. Two eq… [+5082 chars]...